LEP and obesity due to melanocortin 4 receptor deficiency: Based on these facts, PTP1B is a highly plausible candidate for a leptin resistance factor [16] and inhibiting its activity has emerged as a potential therapeutic strategy to treat obesity by restoring leptin sensitivity [17,18].